Prokidney (PROK) Equity Average (2021 - 2026)
Prokidney (PROK) reported Equity Average of -$1.0 billion for Q1 2026, down 2.08% year-over-year from -$1.0 billion in Q1 2025, and down 0.78% quarter-over-quarter from -$1.0 billion in Q4 2025.
Prokidney (PROK) Equity Average (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Equity Average data on file, last reported at -$1.0 billion in Q1 2026.
- Equity Average for Q1 2026 came in at -$1.0 billion, down 2.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (down 2.08% YoY), and the FY2025 annual result was -$1.0 billion, up 4.39% from the prior year.
- Equity Average fell to -$1.0 billion in Q1 2026 per PROK's latest filing, from -$1.0 billion in the prior quarter.
- Over five years, Equity Average peaked at $23.5 million in Q1 2022 and troughed at -$1.5 billion in Q2 2023.
- A 5-year average of -$932.2 million and a median of -$1.0 billion in 2025 frame the typical range for Equity Average.
- The sharpest annual moves came in 2022 and 2023: Equity Average soared 67.95% in 2022, then sank 11048.79% in 2023.
- A 5-year view of Equity Average shows it stood at -$1.1 billion in 2022, then decreased by 0.14% to -$1.1 billion in 2023, then rose by 10.08% to -$987.3 million in 2024, then decreased by 2.26% to -$1.0 billion in 2025, then declined by 0.78% to -$1.0 billion in 2026.
- Business Quant data shows PROK's Equity Average at -$1.0 billion in Q1 2026, -$1.0 billion in Q4 2025, and -$1.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | -1.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.02 Bn |
| Dec 31, 2025 | -1.01 Bn |
| Sep 30, 2025 | -1.01 Bn |
| Jun 30, 2025 | -1.00 Bn |
| Mar 31, 2025 | -996.75 Mn |
| Dec 31, 2024 | -987.33 Mn |
| Sep 30, 2024 | -976.04 Mn |
| Jun 30, 2024 | -1.03 Bn |
| Mar 31, 2024 | -1.10 Bn |
| Dec 31, 2023 | -1.10 Bn |
| Sep 30, 2023 | -1.21 Bn |
| Jun 30, 2023 | -1.46 Bn |
| Mar 31, 2023 | -1.35 Bn |
| Dec 31, 2022 | -1.10 Bn |
| Sep 30, 2022 | -544.89 Mn |
| Jun 30, 2022 | 13.35 Mn |
| Mar 31, 2022 | 23.54 Mn |
| Dec 31, 2021 | 18.66 Mn |
| Sep 30, 2021 | 13.15 Mn |
| Jun 30, 2021 | 7.95 Mn |